MIPS performance and compliance support - at no additional cost to you.
ChartSpan helps you maximize your positive payment adjustment for future Medicare Fee-For-Service reimbursements. We do so by leveraging your Chronic Care Management (CCM) program to incorporate and report on care quality activities that help increase your Merit-based Incentive Payment System (MIPS) score. ChartSpan assigns a dedicated MIPS consultant and provides comprehensive reporting and analytics to track quality performance by working directly with your Quality team and/or ACO – all at no additional cost.
As part of the Centers for Medicare and Medicaid Services’ (CMS) Quality Payment Program (QPP), MIPS is a quality payment incentive program that drives improved healthcare outcomes and reduces costs. MIPS is measured by four performance categories:
- Promoting Interoperability (formerly Meaningful Use)
- Quality (replaces PQRS)
- Improvement Activities
- Cost (replaces VBM)
These four categories are scored and combined into a single compliance program. While a consolidated program eliminates confusion and multiple measures, it also can dramatically improve your fee-for-service revenues and annual earnings through positive payment adjustments.
If you are unsure about your MIPS eligibility, enter your NPI on the Quality Payment Program (QPP) website to determine if you are an eligible clinician.
How ChartSpan Helps You Meet MIPS Goals
Quality is at the heart of MIPS, particularly for patients with complex and chronic conditions – and those are exactly the patients targeted for CCM and AWVs. Our team works to identify gaps in care in your EMR. We then have the ability to talk with your patients about their preventative screenings during their monthly CCM call. We could be talking with them about their quality measures 12 times a year.
Colorectal cancer screening
Breast cancer screening
BMI screening and follow up
Depression screening and follow up
Diabetic eye exam
By participating in ChartSpan's Chronic Care Management program, you may be able to chose to report on some of the improvement activities related to CCM to the Improvement Activities category.
ChartSpan knows it can be difficult to stay on track with your quality initiatives, especially with a program as detailed and complex as MIPS. You can reach out to your dedicated MIPS consultant at any time to ask questions or discuss details of your performance scores.
Substantial Financial Consequences
Providers have up to 9% of their total fee-for-service reimbursements at risk resulting in either an annual decrease or annual increase in reimbursements.
In 2022, the performance threshold is 75, up from 60 last year. Physicians under that level will receive a negative payment adjustment of their Medicare Part B payments.
Physicians whose performance meets or exceeds a final score of 89 points (known as the exceptional performance threshold) will be eligible for an additional positive payment adjustment of their Medicare Part B payments for exceptional performance
For more information on the Final Rule on the 2022 Physician Fee Schedule, read our blog post.
2022 MIPS Categories
|Quality||Cost||Promoting Interoperability||Improvement Activities|
Submit collected data on at least 6 measures or on a complete specialty measure set. In order to ensure data completeness, 70% of the patients who qualify for each measure must be reported on.
For 2022, you must submit data for the same 90 continuous days for certain measures from each of the 4 objective measures. You may be able to submit for some exclusions in this category.
You must submit either:
1) Two high-weighted activities
2) One high-weighted activity and two medium-weighted activities
3) Four medium-weighted activities
CCM activities are included in the various improvement activities to choose from.
Cost is calculated using Medicare Part A ad B claims data by CMS.
Merit-based Incentive Payment System (MIPS) Research
Below are some highlights from the CY2022 Physician Fee Schedule Final Rule: Scoring The maximum negative payment adjustment for PY2022…Read More →